Cargando…
Investigation of HIFU-induced anti-tumor immunity in a murine tumor model
BACKGROUND: High intensity focused ultrasound (HIFU) is an emerging non-invasive treatment modality for localized treatment of cancers. While current clinical strategies employ HIFU exclusively for thermal ablation of the target sites, biological responses associated with both thermal and mechanical...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939831/ https://www.ncbi.nlm.nih.gov/pubmed/17625013 http://dx.doi.org/10.1186/1479-5876-5-34 |
_version_ | 1782134405591990272 |
---|---|
author | Hu, Zhenlin Yang, Xiao Yi Liu, Yunbo Sankin, Georgy N Pua, Eric C Morse, Michael A Lyerly, H Kim Clay, Timothy M Zhong, Pei |
author_facet | Hu, Zhenlin Yang, Xiao Yi Liu, Yunbo Sankin, Georgy N Pua, Eric C Morse, Michael A Lyerly, H Kim Clay, Timothy M Zhong, Pei |
author_sort | Hu, Zhenlin |
collection | PubMed |
description | BACKGROUND: High intensity focused ultrasound (HIFU) is an emerging non-invasive treatment modality for localized treatment of cancers. While current clinical strategies employ HIFU exclusively for thermal ablation of the target sites, biological responses associated with both thermal and mechanical damage from focused ultrasound have not been thoroughly investigated. In particular, endogenous danger signals from HIFU-damaged tumor cells may trigger the activation of dendritic cells. This response may play a critical role in a HIFU-elicited anti-tumor immune response which can be harnessed for more effective treatment. METHODS: Mice bearing MC-38 colon adenocarcinoma tumors were treated with thermal and mechanical HIFU exposure settings in order to independently observe HIFU-induced effects on the host's immunological response. In vivo dendritic cell activity was assessed along with the host's response to challenge tumor growth. RESULTS: Thermal and mechanical HIFU were found to increase CD11c+ cells 3.1-fold and 4-fold, respectively, as compared to 1.5-fold observed for DC injection alone. In addition, thermal and mechanical HIFU increased CFSE+ DC accumulation in draining lymph nodes 5-fold and 10-fold, respectively. Moreover, focused ultrasound treatments not only caused a reduction in the growth of primary tumors, with tumor volume decreasing by 85% for thermal HIFU and 43% for mechanical HIFU, but they also provided protection against subcutaneous tumor re-challenge. Further immunological assays confirmed an enhanced CTL activity and increased tumor-specific IFN-γ-secreting cells in the mice treated by focused ultrasound, with cytotoxicity induced by mechanical HIFU reaching as high as 27% at a 10:1 effector:target ratio. CONCLUSION: These studies present initial encouraging results confirming that focused ultrasound treatment can elicit a systemic anti-tumor immune response, and they suggest that this immunity is closely related to dendritic cell activation. Because DC activation was more pronounced when tumor cells were mechanically lysed by focused ultrasound treatment, mechanical HIFU in particular may be employed as a potential strategy in combination with subsequent thermal ablations for increasing the efficacy of HIFU cancer treatment by enhancing the host's anti-tumor immunity. |
format | Text |
id | pubmed-1939831 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-19398312007-08-04 Investigation of HIFU-induced anti-tumor immunity in a murine tumor model Hu, Zhenlin Yang, Xiao Yi Liu, Yunbo Sankin, Georgy N Pua, Eric C Morse, Michael A Lyerly, H Kim Clay, Timothy M Zhong, Pei J Transl Med Research BACKGROUND: High intensity focused ultrasound (HIFU) is an emerging non-invasive treatment modality for localized treatment of cancers. While current clinical strategies employ HIFU exclusively for thermal ablation of the target sites, biological responses associated with both thermal and mechanical damage from focused ultrasound have not been thoroughly investigated. In particular, endogenous danger signals from HIFU-damaged tumor cells may trigger the activation of dendritic cells. This response may play a critical role in a HIFU-elicited anti-tumor immune response which can be harnessed for more effective treatment. METHODS: Mice bearing MC-38 colon adenocarcinoma tumors were treated with thermal and mechanical HIFU exposure settings in order to independently observe HIFU-induced effects on the host's immunological response. In vivo dendritic cell activity was assessed along with the host's response to challenge tumor growth. RESULTS: Thermal and mechanical HIFU were found to increase CD11c+ cells 3.1-fold and 4-fold, respectively, as compared to 1.5-fold observed for DC injection alone. In addition, thermal and mechanical HIFU increased CFSE+ DC accumulation in draining lymph nodes 5-fold and 10-fold, respectively. Moreover, focused ultrasound treatments not only caused a reduction in the growth of primary tumors, with tumor volume decreasing by 85% for thermal HIFU and 43% for mechanical HIFU, but they also provided protection against subcutaneous tumor re-challenge. Further immunological assays confirmed an enhanced CTL activity and increased tumor-specific IFN-γ-secreting cells in the mice treated by focused ultrasound, with cytotoxicity induced by mechanical HIFU reaching as high as 27% at a 10:1 effector:target ratio. CONCLUSION: These studies present initial encouraging results confirming that focused ultrasound treatment can elicit a systemic anti-tumor immune response, and they suggest that this immunity is closely related to dendritic cell activation. Because DC activation was more pronounced when tumor cells were mechanically lysed by focused ultrasound treatment, mechanical HIFU in particular may be employed as a potential strategy in combination with subsequent thermal ablations for increasing the efficacy of HIFU cancer treatment by enhancing the host's anti-tumor immunity. BioMed Central 2007-07-11 /pmc/articles/PMC1939831/ /pubmed/17625013 http://dx.doi.org/10.1186/1479-5876-5-34 Text en Copyright © 2007 Hu et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Hu, Zhenlin Yang, Xiao Yi Liu, Yunbo Sankin, Georgy N Pua, Eric C Morse, Michael A Lyerly, H Kim Clay, Timothy M Zhong, Pei Investigation of HIFU-induced anti-tumor immunity in a murine tumor model |
title | Investigation of HIFU-induced anti-tumor immunity in a murine tumor model |
title_full | Investigation of HIFU-induced anti-tumor immunity in a murine tumor model |
title_fullStr | Investigation of HIFU-induced anti-tumor immunity in a murine tumor model |
title_full_unstemmed | Investigation of HIFU-induced anti-tumor immunity in a murine tumor model |
title_short | Investigation of HIFU-induced anti-tumor immunity in a murine tumor model |
title_sort | investigation of hifu-induced anti-tumor immunity in a murine tumor model |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1939831/ https://www.ncbi.nlm.nih.gov/pubmed/17625013 http://dx.doi.org/10.1186/1479-5876-5-34 |
work_keys_str_mv | AT huzhenlin investigationofhifuinducedantitumorimmunityinamurinetumormodel AT yangxiaoyi investigationofhifuinducedantitumorimmunityinamurinetumormodel AT liuyunbo investigationofhifuinducedantitumorimmunityinamurinetumormodel AT sankingeorgyn investigationofhifuinducedantitumorimmunityinamurinetumormodel AT puaericc investigationofhifuinducedantitumorimmunityinamurinetumormodel AT morsemichaela investigationofhifuinducedantitumorimmunityinamurinetumormodel AT lyerlyhkim investigationofhifuinducedantitumorimmunityinamurinetumormodel AT claytimothym investigationofhifuinducedantitumorimmunityinamurinetumormodel AT zhongpei investigationofhifuinducedantitumorimmunityinamurinetumormodel |